KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Free Cash Flow (2017 - 2025)

Guardant Health (GH) has disclosed Free Cash Flow for 9 consecutive years, with -$54.2 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 4.05% to -$54.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$233.1 million through Dec 2025, up 4.35% year-over-year, with the annual reading at -$233.1 million for FY2025, 4.35% up from the prior year.
  • Free Cash Flow hit -$54.2 million in Q4 2025 for Guardant Health, down from -$45.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$22.2 million in Q1 2021 to a low of -$135.0 million in Q2 2022.
  • Historically, Free Cash Flow has averaged -$67.9 million across 5 years, with a median of -$66.5 million in 2021.
  • Biggest YoY gain for Free Cash Flow was 61.06% in 2021; the steepest drop was 1239.64% in 2021.
  • Year by year, Free Cash Flow stood at -$35.5 million in 2021, then increased by 10.97% to -$31.6 million in 2022, then plummeted by 162.21% to -$82.8 million in 2023, then skyrocketed by 37.07% to -$52.1 million in 2024, then fell by 4.05% to -$54.2 million in 2025.
  • Business Quant data shows Free Cash Flow for GH at -$54.2 million in Q4 2025, -$45.8 million in Q3 2025, and -$65.9 million in Q2 2025.